Research on Japan's innovative drug R&D incentive policy and its enlightenment to China——an empirical study based on Takeda Pharmaceutical Company

YAN Jian-zhou; ZHU Jia-wen; CHEN Yan-yun; LIU Jia-yuan

doi:10.3969/j.issn.1003-3734.2021.13.001

Home>Articles>Research on Japan's innovative drug R&D incentive policy and its enlightenment to China——an empirical study based on Takeda Pharmaceutical Company

DOI: 10.3969/j.issn.1003-3734.2021.13.001

Research on Japan's innovative drug R&D incentive policy and its enlightenment to China——an empirical study based on Takeda Pharmaceutical Company

YAN Jian-zhou

ZHU Jia-wen

CHEN Yan-yun

LIU Jia-yuan

Machine-generated Keywords：

Publication Date：2021-07-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：7( 1153-1159 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2021,30(13)